TerrAscend Secures US$120 Million Term Loan To Fund Ilera Earn-Out Payment

TerrAscend Corp (CSE: TER) this morning announced that it has closed on a US$120 million senior secured term loan with a syndicate of lenders. The term loan was required following what is said to be strong performance exhibited by Ilera Healthcare Division, requiring the company to payout the entire earnout provision of the transaction, of which US$135 million remains.

Ilera was originally acquired by TerrAscend back in September 2019 for proceeds of up to US$225 million, a figure that is based on the full earn-out incentive structure being met. The company operates in Pennsylvania, housing a 144,000 square foot cultivation and manufacturing facility along with three dispensaries.

The term loan, arranged by Seaport Global Securities, will see the assets of Ilera secured against the debts. The loan bears interest at a rate of 12.875% per annum, with a four year maturity on the debt while being callable at any time. With an initial value of US$120 million, the company is able to expand the loan by up to US$30 million subject to certain conditions being met.

The funds from the raise will be used in entirety to fund the earn-out payments required to be made to Ilera, with the remaining portion owed to be paid via cash on hand.

TerrAscend Corp last traded at $12.33 on the CSE.


Information for this briefing was found via Sedar and TerrAscend Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Tracking Ahead Of Guidance Following Q1 Production Results

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Related News

TerrAscend Hits US$49.7 Million In Revenue, US$16.0 Million Net Loss In Q1 2022

TerrAscend Corp. (CSE: TER) reported late Thursday its Q1 2022 financial results, which saw the...

Friday, May 13, 2022, 10:14:00 AM

TerrAscend Moves To Be First TSX-Listed US Cannabis Operator

TerrAscend Corp (CSE: TER) is moving to be one of the first cannabis issuers on...

Tuesday, March 14, 2023, 09:03:48 AM

Stifel Reinitiates Coverage On Eight Cannabis Operators

Earlier this week, Stifel released a new report on cannabis operations, focused predominantly on US-based...

Friday, July 24, 2020, 03:30:00 PM

TerrAscend: Analyst Consensus Estimates For Q3 2021

TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before...

Monday, November 15, 2021, 02:17:00 PM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM